Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents, Phytogenic | 3 | 2020 | 110 | 1.920 |
Why?
|
| Chemokine CCL2 | 4 | 2022 | 85 | 1.630 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2023 | 807 | 1.540 |
Why?
|
| Gossypol | 2 | 2020 | 5 | 1.420 |
Why?
|
| Cell Proliferation | 12 | 2023 | 1198 | 1.390 |
Why?
|
| Apoptosis | 9 | 2024 | 1398 | 1.370 |
Why?
|
| Naphthoquinones | 2 | 2018 | 36 | 1.210 |
Why?
|
| Cell Line, Tumor | 14 | 2024 | 2231 | 1.060 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 803 | 1.040 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2020 | 147 | 0.970 |
Why?
|
| 3T3-L1 Cells | 1 | 2024 | 16 | 0.970 |
Why?
|
| Anti-Obesity Agents | 1 | 2024 | 10 | 0.970 |
Why?
|
| Vitis | 1 | 2024 | 31 | 0.930 |
Why?
|
| Adipocytes | 1 | 2024 | 58 | 0.930 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 269 | 0.830 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 1502 | 0.810 |
Why?
|
| Plant Extracts | 1 | 2024 | 286 | 0.770 |
Why?
|
| Iridoids | 1 | 2020 | 5 | 0.760 |
Why?
|
| Depsides | 1 | 2020 | 3 | 0.750 |
Why?
|
| Cinnamates | 1 | 2020 | 6 | 0.750 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 88 | 0.740 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2023 | 356 | 0.730 |
Why?
|
| Interleukin-8 | 1 | 2020 | 60 | 0.720 |
Why?
|
| Cell Cycle | 2 | 2021 | 326 | 0.700 |
Why?
|
| NF-kappa B | 2 | 2022 | 339 | 0.690 |
Why?
|
| Contraceptive Agents, Male | 1 | 2019 | 3 | 0.690 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 251 | 0.620 |
Why?
|
| Obesity | 1 | 2024 | 1067 | 0.540 |
Why?
|
| Microglia | 1 | 2017 | 166 | 0.530 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 149 | 0.530 |
Why?
|
| Cytokines | 2 | 2021 | 602 | 0.500 |
Why?
|
| Humans | 22 | 2024 | 37093 | 0.450 |
Why?
|
| Signal Transduction | 5 | 2023 | 1908 | 0.430 |
Why?
|
| Allyl Compounds | 2 | 2024 | 47 | 0.420 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1015 | 0.410 |
Why?
|
| Flavonoids | 2 | 2021 | 87 | 0.360 |
Why?
|
| Female | 11 | 2024 | 20969 | 0.350 |
Why?
|
| Cell Survival | 4 | 2021 | 864 | 0.350 |
Why?
|
| Sulfides | 2 | 2024 | 62 | 0.250 |
Why?
|
| Garlic | 1 | 2024 | 30 | 0.240 |
Why?
|
| Xanthophylls | 1 | 2023 | 15 | 0.240 |
Why?
|
| Anticarcinogenic Agents | 1 | 2024 | 65 | 0.230 |
Why?
|
| Precancerous Conditions | 1 | 2024 | 82 | 0.220 |
Why?
|
| Benzophenanthridines | 1 | 2022 | 9 | 0.220 |
Why?
|
| Fruit | 1 | 2024 | 173 | 0.210 |
Why?
|
| Antioxidants | 2 | 2024 | 416 | 0.210 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 219 | 0.210 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 461 | 0.210 |
Why?
|
| Biological Products | 1 | 2023 | 71 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 152 | 0.210 |
Why?
|
| Isoquinolines | 1 | 2022 | 45 | 0.210 |
Why?
|
| I-kappa B Kinase | 1 | 2022 | 44 | 0.210 |
Why?
|
| Caspase 3 | 2 | 2023 | 207 | 0.200 |
Why?
|
| Epithelial Cells | 2 | 2024 | 384 | 0.200 |
Why?
|
| Cell Movement | 2 | 2022 | 571 | 0.200 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2021 | 35 | 0.200 |
Why?
|
| Vimentin | 1 | 2021 | 37 | 0.190 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 213 | 0.190 |
Why?
|
| Chemokine CXCL1 | 1 | 2021 | 15 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 122 | 0.190 |
Why?
|
| Hydrolyzable Tannins | 1 | 2021 | 16 | 0.190 |
Why?
|
| Cell Differentiation | 1 | 2024 | 587 | 0.190 |
Why?
|
| RNA, Messenger | 3 | 2022 | 1207 | 0.190 |
Why?
|
| Antigens, CD | 1 | 2021 | 121 | 0.190 |
Why?
|
| Cadherins | 1 | 2021 | 90 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 169 | 0.190 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2020 | 3 | 0.190 |
Why?
|
| Osteoprotegerin | 1 | 2020 | 10 | 0.190 |
Why?
|
| Breast | 1 | 2021 | 135 | 0.180 |
Why?
|
| Mice | 2 | 2024 | 5913 | 0.180 |
Why?
|
| Monoamine Oxidase | 1 | 2020 | 34 | 0.180 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2020 | 25 | 0.180 |
Why?
|
| Chalcones | 1 | 2019 | 14 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 197 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 239 | 0.160 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 229 | 0.160 |
Why?
|
| Paclitaxel | 1 | 2018 | 50 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 502 | 0.160 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 91 | 0.150 |
Why?
|
| Quality of Life | 1 | 2022 | 481 | 0.150 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2017 | 115 | 0.150 |
Why?
|
| Lysine | 1 | 2017 | 113 | 0.140 |
Why?
|
| Mutation | 1 | 2022 | 1095 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2020 | 517 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 220 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2021 | 426 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2017 | 316 | 0.130 |
Why?
|
| Animals | 2 | 2024 | 15081 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1039 | 0.120 |
Why?
|
| Depression | 1 | 2020 | 712 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2023 | 16 | 0.110 |
Why?
|
| Benzoquinones | 2 | 2022 | 36 | 0.100 |
Why?
|
| Benzo(a)pyrene | 2 | 2024 | 126 | 0.100 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2022 | 77 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 935 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2022 | 435 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2022 | 513 | 0.090 |
Why?
|
| Middle Aged | 1 | 2022 | 10129 | 0.070 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2023 | 3 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2024 | 51 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2023 | 6 | 0.060 |
Why?
|
| Carotenoids | 1 | 2023 | 70 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 161 | 0.050 |
Why?
|
| Chemokines | 1 | 2023 | 97 | 0.050 |
Why?
|
| DNA Repair | 1 | 2024 | 188 | 0.050 |
Why?
|
| DNA Polymerase beta | 1 | 2021 | 13 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2021 | 24 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2022 | 190 | 0.050 |
Why?
|
| Glutathione | 1 | 2022 | 179 | 0.050 |
Why?
|
| DNA | 1 | 2024 | 574 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 83 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2020 | 109 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 674 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 409 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 708 | 0.040 |
Why?
|
| Models, Biological | 1 | 2021 | 677 | 0.040 |
Why?
|
| Inflammation | 1 | 2021 | 618 | 0.030 |
Why?
|
| Male | 1 | 2020 | 20025 | 0.010 |
Why?
|